{"id":"https://openalex.org/W2109267124","doi":null,"title":"A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.","display_name":"A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W2109267124","mag":"2109267124","pmid":"https://pubmed.ncbi.nlm.nih.gov/11595692"},"language":"en","primary_location":{"id":"pmid:11595692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066484657","display_name":"Peter C. Adamson","orcid":"https://orcid.org/0000-0002-9487-757X","observed_orcids":["https://orcid.org/0000-0002-9487-757X"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P C Adamson","raw_affiliation_strings":["Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA. adamson@email.chop.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA. adamson@email.chop.edu","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071679104","display_name":"Brigitte C. Widemann","orcid":"https://orcid.org/0000-0002-9198-7175","observed_orcids":["https://orcid.org/0000-0002-9198-7175"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B C Widemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019914745","display_name":"Gregory H. Reaman","orcid":"https://orcid.org/0000-0002-6698-4503","observed_orcids":["https://orcid.org/0000-0002-6698-4503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G H Reaman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048397868","display_name":"Nita L. Seibel","orcid":"https://orcid.org/0000-0001-6259-7955","observed_orcids":["https://orcid.org/0000-0001-6259-7955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N L Seibel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061773929","display_name":"Robert F. Murphy","orcid":"https://orcid.org/0000-0003-0358-901X","observed_orcids":["https://orcid.org/0000-0003-0358-901X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R F Murphy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041267710","display_name":"A F Gillespie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A F Gillespie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F M Balis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3491,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.5678755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"7","issue":"10","first_page":"3034","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/9-cis-retinoic-acid","display_name":"9-cis-retinoic acid","score":0.9800000190734863},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.765999972820282},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.8820000290870667},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.890999972820282},{"id":"https://openalex.org/keywords/idiopathic-intracranial-hypertension","display_name":"idiopathic intracranial hypertension","score":0.8939999938011169},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8040000200271606},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9210000038146973},{"id":"https://openalex.org/keywords/plasma-concentration-variability","display_name":"plasma concentration variability","score":0.5400000214576721},{"id":"https://openalex.org/keywords/chronic-dosing","display_name":"chronic dosing","score":0.5339999794960022},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7120000123977661},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.6489999890327454},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5540000200271606},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.5379999876022339},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8501565456390381},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5889092087745667},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5778583288192749},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5600825548171997},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5457635521888733},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5240535736083984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45780158042907715},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4528634250164032},{"id":"https://openalex.org/C2993561819","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric cancer","level":3,"score":0.4307985305786133},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077556","descriptor_name":"Alitretinoin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11595692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2109267124","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1139052334","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"U10CA017829","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1442326793","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"5u10ca010198-32","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1805336324","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"2u10ca002971-43","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1929337571","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"5u10ca028882-22","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1997256092","display_name":"CANCER IN CHILDREN","funder_award_id":"5u10ca026270-20","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2431522051","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"5u10ca036015-15","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G372727100","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"5u10ca010382-35","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4254236046","display_name":"CHILDRENS CANCER GROUP CHAIRMANS AWARD","funder_award_id":"U10CA013539","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G603988732","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"5u10ca026126-22","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6671770440","display_name":"CHILDRENS CANCER GROUP","funder_award_id":"U10CA003888","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W61706947","https://openalex.org/W189999947","https://openalex.org/W345719706","https://openalex.org/W1539454494","https://openalex.org/W1570165358","https://openalex.org/W1590126849","https://openalex.org/W1768782404","https://openalex.org/W1801634746","https://openalex.org/W1873259379","https://openalex.org/W1967863783","https://openalex.org/W1971376244","https://openalex.org/W1973929985","https://openalex.org/W1978050245","https://openalex.org/W1980728760","https://openalex.org/W1987269203","https://openalex.org/W2014591899","https://openalex.org/W2017578370","https://openalex.org/W2018309349","https://openalex.org/W2041270901","https://openalex.org/W2047556064","https://openalex.org/W2049791242","https://openalex.org/W2057721716","https://openalex.org/W2064428081","https://openalex.org/W2072233737","https://openalex.org/W2074136646","https://openalex.org/W2076108719","https://openalex.org/W2083436346","https://openalex.org/W2083783597","https://openalex.org/W2091787441","https://openalex.org/W2115494923","https://openalex.org/W2123135689","https://openalex.org/W2126957032","https://openalex.org/W2136660513","https://openalex.org/W2137848171","https://openalex.org/W2140179531","https://openalex.org/W2146154927","https://openalex.org/W2164272507","https://openalex.org/W2168731357","https://openalex.org/W2177441413","https://openalex.org/W2185703542","https://openalex.org/W2327522594","https://openalex.org/W2407362156","https://openalex.org/W2417687315","https://openalex.org/W2421553221","https://openalex.org/W2428721005"],"related_works":["https://openalex.org/W2177441413","https://openalex.org/W1801634746","https://openalex.org/W2136660513","https://openalex.org/W2027884825","https://openalex.org/W2319271682","https://openalex.org/W2421359688","https://openalex.org/W2083384978","https://openalex.org/W1932572494","https://openalex.org/W2104830807","https://openalex.org/W1590126849"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2,33],"the":[3,9,28,96,101,137,162,193,222,235,240,281],"maximum":[4],"tolerated":[5],"dose":[6,69,140,164,194,306],"and":[7,25,32,55,83,93,113,173,221,292,314,321],"describe":[8],"toxicities":[10],"of":[11,30,95,111,118,128,157,166,192,208,214,232,246,256,272,283,289,307,317],"9-cis-retinoic":[12],"acid":[13],"(9cRA,":[14],"ALRT1057)":[15],"administered":[16,297],"p.o.":[17,61,219],"tid":[18],"in":[19,133,187,201,258,309],"pediatric":[20,259],"patients":[21,103,106,115,125,135,143,152,160,175,189,260,310],"with":[22,39,46,60,77],"refractory":[23,47],"cancer":[24,48],"to":[26,80,278],"study":[27],"pharmacokinetics":[29,282],"9cRA":[31,62,202,209,233,237,257,273,284,308],"whether":[34],"systemic":[35],"drug":[36],"exposure":[37],"changes":[38],"chronic":[40],"dosing.":[41],"PATIENTS":[42],"AND":[43],"METHODS:":[44],"Children":[45],"(stratified":[49],"by":[50,243],"age,":[51,129,158],"<":[52,107,153,311],"or":[53,108,154,312],"=12":[54,109,155,313],">12":[56,116,126,315],"years)":[57],"were":[58,120],"treated":[59],"for":[63,122],"28":[64],"consecutive":[65],"days.":[66],"The":[67,253,302],"starting":[68,163],"was":[70,88,185,197,226,261],"50":[71,167],"mg/m(2)/day":[72,139,146,168],"divided":[73],"into":[74],"3":[75],"doses":[76,271],"planned":[78],"escalations":[79],"65,":[81],"85,":[82],"110":[84,138],"mg/m(2)/day.":[85,181],"Pharmacokinetic":[86],"sampling":[87],"performed":[89],"on":[90,298],"days":[91],"1":[92,250],"29":[94,231],"first":[97],"cycle.":[98],"RESULTS:":[99],"Of":[100],"37":[102],"entered,":[104],"18":[105],"years":[110,117,127,156,316],"age":[112,119,318],"11":[114],"evaluable":[121],"toxicity.":[123],"In":[124,151],"dose-limiting":[130,148,170,177,254],"headache":[131],"occurred":[132,210],"2/2":[134],"at":[136,144,161,179,211],"level;":[141],"1/8":[142],"85":[145,322],"developed":[147,169],"pseudotumor":[149,171,264],"cerebri.":[150,265],"3/5":[159],"level":[165],"cerebri;":[172],"0/6":[174],"experienced":[176],"toxicity":[178,255],"35":[180,320],"Reversible":[182],"non-dose-limiting":[183],"hepatotoxicity":[184],"observed":[186],"15":[188],"across":[190],"all":[191],"levels.":[195],"There":[196],"considerable":[198],"interpatient":[199,290],"variability":[200,291],"plasma":[203,206,236],"concentrations.":[204],"Peak":[205],"concentrations":[207],"a":[212,218,286,299],"median":[213],"1.5":[215],"h":[216],"after":[217],"dose,":[220],"harmonic-mean":[223],"terminal":[224],"half-life":[225],"43":[227],"min.":[228],"By":[229],"day":[230,249],"administration,":[234],"area":[238],"under":[239],"curve":[241],"declined":[242],"an":[244],"average":[245],"65%":[247],"from":[248],"values.":[251],"CONCLUSIONS:":[252],"neurotoxicity,":[262],"primarily":[263],"Younger":[266],"children":[267],"tolerate":[268],"significantly":[269],"lower":[270],"than":[274],"older":[275],"children.":[276],"Similar":[277],"all-trans-retinoic":[279],"acid,":[280],"demonstrated":[285],"wide":[287],"degree":[288],"decreased":[293],"over":[294],"time":[295],"when":[296],"daily":[300],"basis.":[301],"recommended":[303],"Phase":[304],"II":[305],"is":[319],"mg/m(2)/day,":[323],"respectively.":[324]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}